Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232545 | PMC |
| http://dx.doi.org/10.1200/PO.20.00444 | DOI Listing |
Publication Analysis
Top Keywords
debio1347 oral
4
oral fgfr
4
fgfr inhibitor
4
inhibitor single-center
4
single-center study
4
study pediatric
4
pediatric patients
4
patients recurrent
4
recurrent refractory
4
refractory fgfr-altered
4
Similar Publications
Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.
JCO Precis Oncol
March 2022
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!